Our mission

IBM Watson Health is committed to helping build smarter health ecosystems.

This means working with you to help you achieve simpler processes, better care insights, faster breakthroughs and improved experiences for people around the world.

The combination of our core strengths — our deep industry experience in health, our technology solutions including options for AI and data analytics, and our reputation for trust and security — helps us to deliver support for our clients' digital transformations.

Importance of research

Research has been essential from the beginning

IBM has had a longstanding tradition of investing in research, and that tradition continues with Watson Health. Since the inception of Watson Health, more than 2,000 publications from across Watson Health and IBM Research have been published that are aimed at tackling critical challenges in health and healthcare.

The Health Officers Pursuing Excellence and Evidence (HOPE) Team provides crucial support for research with clinical and scientific leadership across IBM Watson Health. The diverse membership of the team spans fields such as healthcare delivery and leadership, biomedical informatics and research, data science, engineering, technical development, and consulting.

Scientific updates

At the end of each quarter, the HOPE Team publishes a sampling of key health-related scientific evidence from IBM, Watson Health, and their partners.


Iconic moments for IBM in health.

Polio research number crunching machine

IBM machines provide the muscle for Dr. Jonas Salk's polio research. Producing 1,800,000 punch cards on the test children, and cutting years off the search for a polio vaccine.

Discover heatless laser process

IBM announces the discovery of a new heatless laser etching process, with the potential for unprecedented precision in surgical incisions, ultimately leading to LASIK eye surgery. 

Ultrasound can detect disease

Researchers at the IBM Scientific Center in Haifa, Israel, explore the use of ultrasound to detect diseases of the liver and coronary artery, and congenital disorders of the heart.

Detect defects in DNA

IBM reports that scientists from IBM's Zurich Research Laboratory and the University of Basel find a new approach for using tiny biochemical "machines" made of silicon to detect defects in DNA, which could eventually lead to new medical treatments.

Next steps